Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP

NCT03899077 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Prostate

Interventions

DRUG: Apalutamide
DRUG: Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial
DRUG: Goserelin Acetate 10.8 MG Subcutaneous Implant
DRUG: Triptorelin Pamoate
DRUG: Degarelix acetate

Sponsor

Cancer Research Antwerp

Collaborators

[object Object]